Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients

Efficacy and safety of TNF-α inhibitors in refractory primary complex aphthosis: a patient series and overview of the literature

(2013) Freja Lærke Sand et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review

(2012) Dominique C. van Rappard et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis

(2012) Robert J. Pariser et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

(2011) H.H. van der Zee et al.   BRITISH JOURNAL OF DERMATOLOGY

Tumor necrosis factor biologics beyond psoriasis in dermatology

(2011) Raj Patel et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Successful treatment of granulomatous cheilitis with adalimumab

(2011) Ricardo Ruiz Villaverde et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Efficacy of tumour necrosis factor-α antagonists in aphthous ulceration: review of published individual patient data

(2011) I.D. O’Neill   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents?

(2009) L Matusiak et al.   ACTA DERMATO-VENEREOLOGICA

Etanercept Treatment in Sweet's Syndrome with Inflammatory Arthritis

(2009) N. L. AMBROSE et al.   JOURNAL OF RHEUMATOLOGY

Sneddon-Wilkinson disease treated with etanercept: report of two cases

(2008) D. R. Berk et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY